Related Experiment Video

Updated: Aug 4, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Vaccine prevention of acute otitis media

D P Greenberg1, A Hoberman

  • 1Department of Pediatrics, University of Pittsburgh School of Medicine, Division of Allergy, Immunology and Infectious Diseases, Children's Hospital of Pittsburgh, Room 4B-320, 3705 Fifth Avenue, Pittsburgh, PA 15213-2583, USA. greenbd@chplink.chp.edu

Current Allergy and Asthma Reports
|March 15, 2002
PubMed

Insights

Vaccines targeting common respiratory viruses like RSV and influenza, alongside bacterial pathogens such as Streptococcus pneumoniae, show promise in reducing acute otitis media (AOM) incidence in young children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Acute otitis media (AOM) incidence is rising in US infants and children.
  • AOM frequently follows viral upper respiratory tract infections (URTIs), including those caused by respiratory syncytial virus (RSV), influenza virus (IV), and parainfluenza virus (PIV).
  • Viral infections can lead to eustachian tube dysfunction, a key factor in AOM development.

Purpose of the Study:

  • To explore the potential of vaccines in preventing AOM.
  • To review the impact of existing and developing vaccines against viral and bacterial AOM pathogens.

Main Methods:

  • Review of previous studies on influenza virus vaccines and AOM.
  • Assessment of ongoing clinical trials for RSV and PIV type 3 vaccines.
  • Evaluation of the effectiveness of the heptavalent pneumococcal conjugate vaccine against AOM.
  • Overview of vaccine development for nontypeable Haemophilus influenzae (NTHi) and Moraxella catarrhalis.

Main Results:

  • Previous studies demonstrated that influenza virus vaccines reduced AOM incidence by 30% to 36%.
  • Vaccines for RSV and PIV type 3 are currently in clinical trials.
  • The heptavalent pneumococcal conjugate vaccine is effective against vaccine-serotype invasive disease and AOM.
  • Vaccine candidates for NTHi and M. catarrhalis are in development.

Conclusions:

  • Vaccination against common viral URTIs could significantly decrease AOM incidence.
  • Development of vaccines targeting key bacterial pathogens like S. pneumoniae, NTHi, and M. catarrhalis is crucial for comprehensive AOM prevention.
  • Further research and clinical testing of vaccines against RSV, PIV, NTHi, and M. catarrhalis are warranted to combat the rising rates of AOM.

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Related Concept Videos

Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...